Progress of Gd-EOB-DTPA in diagnosis of hepatocellular carcinoma
10.3969/J.ISSN.1672-8270.2016.10.040
- VernacularTitle:肝细胞特异性造影剂钆塞酸二钠诊断肝细胞肝癌的研究进展
- Author:
Yan YANG
;
Xin DONG
- Publication Type:Journal Article
- Keywords:
Hepatocellular carcinoma;
Magnetic resonance imaging;
Gadolinium ethoxyben zyldiethylenetriaminepentaacetic acid;
Contrast agent
- From:
China Medical Equipment
2016;13(10):137-140,141
- CountryChina
- Language:Chinese
-
Abstract:
The liver specific contrast agent gadolinium ethoxybenzyldiethylenetriaminepe ntaacetic acid (Gd-EOB-DTPA) is routinely used in clinical magnetic resonance imaging. It combines assessment of tissue perfusion during the vascular phase with hepatocyte specific imaging during the hepatobiliary phase. This combination of imaging properties has been shown to provide excellent results in the detection and differentiation of liver lesions. The enhancement characteristics of Gd-EOB-DTPA in hepatocellular carcinoma, regenerative nodules and degenerated nodules were summarized in this review. Liver cell specific contrast agent can further improve the diagnostic ability.
